Literature DB >> 20225280

Muscle magnetic resonance imaging involvement in muscular dystrophies with rigidity of the spine.

Eugenio Mercuri1, Emma Clements, Amaka Offiah, Anna Pichiecchio, Gessica Vasco, Flaviana Bianco, Angela Berardinelli, Adnan Manzur, Marika Pane, Sonia Messina, Francesca Gualandi, Enzo Ricci, Mary Rutherford, Francesco Muntoni.   

Abstract

OBJECTIVE: The aim of the study was to evaluate whether the visual analysis of muscle magnetic resonance imaging scans can identify specific patterns of muscle involvement.
METHODS: We assessed scans from 83 patients with muscle disorders characterized by rigidity of the spine secondary to mutations in 4 different genes. The conditions studied were rigid spine syndrome (SEPN1 defects), Bethlem myopathy, and Ullrich congenital muscular dystrophy, allelic disorders caused by Col6A1, Col6A2, and Col6A3 mutations, the autosomal dominant form of Emery-Dreifuss muscular dystrophy (LMNA defects) and calpain-deficient limb girdle muscular dystrophy (CAPN3 defects). The scans of 25 patients affected by other myopathies were also reviewed as a control group. The scans were compared with the previously described patterns.
RESULTS: In 82% of the scans in the study group (68/83) the patterns were classified as "typical" of 1 of the 5 forms studied, and in 7 (8%) were consistent with 1 of the reported patterns but not entirely typical. With one exception, the patterns identified were always consistent with the appropriate genetic diagnosis. The remaining scans (9%) had only minimal changes and were uninformative. None of the scans of the 25 patients in the control group had patterns that could be classified as typical of the 5 forms examined. The sensitivity to detect selective patterns in relation to the genetic diagnosis was 0.9.
INTERPRETATION: These findings suggest that muscle magnetic resonance imaging could be used in clinical practice as an additional tool in the differential diagnosis of muscle disorders with prominent spinal rigidity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20225280     DOI: 10.1002/ana.21846

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  44 in total

1.  Clinical utility gene card for: Multi-minicore disease.

Authors:  Suzanne Lillis; Steve Abbs; Ana Ferreiro; Francesco Muntoni; Heinz Jungbluth
Journal:  Eur J Hum Genet       Date:  2011-10-19       Impact factor: 4.246

2.  Ullrich Congenital Muscular Dystrophy Possibly Related With COL6A1 p.Gly302Arg Variant.

Authors:  Yoonhong Park; Myung Seok Park; Duk Hyun Sung; Ji Yeon Sohn; Chang-Seok Ki; Du-Hwan Kim
Journal:  Ann Rehabil Med       Date:  2014-04-29

Review 3.  The collagen VI-related myopathies Ullrich congenital muscular dystrophy and Bethlem myopathy.

Authors:  Carsten G Bönnemann
Journal:  Handb Clin Neurol       Date:  2011

4.  Do's and don'ts in the preparation of muscle cryosections for histological analysis.

Authors:  Ajay Kumar; Anthony Accorsi; Younghwa Rhee; Mahasweta Girgenrath
Journal:  J Vis Exp       Date:  2015-05-15       Impact factor: 1.355

5.  Muscle MRI in Bethlem myopathy.

Authors:  Jasper M Morrow; Robert D S Pitceathly; Ros M Quinlivan; Tarek A Yousry
Journal:  BMJ Case Rep       Date:  2013-04-16

6.  Muscle MRI findings in a one-year-old girl with merosin-deficient congenital muscular dystrophy type 1A due to LAMA2 mutation: A case report.

Authors:  Yingyin Liang; Guidian Li; Songlin Chen; Rongxing He; Xiangxue Zhou; Yingming Chen; Xue Xu; Ronglan Zhu; Cheng Zhang
Journal:  Biomed Rep       Date:  2017-06-29

7.  Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy: Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Issues Review Panel of the American Association of Neuromuscular & Electrodiagnostic Medicine.

Authors:  Peter B Kang; Leslie Morrison; Susan T Iannaccone; Robert J Graham; Carsten G Bönnemann; Anne Rutkowski; Joseph Hornyak; Ching H Wang; Kathryn North; Maryam Oskoui; Thomas S D Getchius; Julie A Cox; Erin E Hagen; Gary Gronseth; Robert C Griggs
Journal:  Neurology       Date:  2015-03-31       Impact factor: 9.910

8.  Muscular involvement assessed by MRI correlates to motor function measurement values in oculopharyngeal muscular dystrophy.

Authors:  Arne Fischmann; Monika Gloor; Susanne Fasler; Tanja Haas; Rachele Rodoni Wetzel; Oliver Bieri; Stephan Wetzel; Karl Heinimann; Klaus Scheffler; Dirk Fischer
Journal:  J Neurol       Date:  2011-02-22       Impact factor: 4.849

Review 9.  Advancements in magnetic resonance imaging-based biomarkers for muscular dystrophy.

Authors:  Doris G Leung
Journal:  Muscle Nerve       Date:  2019-05-14       Impact factor: 3.217

10.  Muscle MRI in muscular dystrophies.

Authors:  Jordi Díaz-Manera; Jaume Llauger; Eduard Gallardo; Isabel Illa
Journal:  Acta Myol       Date:  2015-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.